# Olive Leaf Extracts in the Control of Cardiovascular Risk

> **NCT05297110** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of Monastir** · enrollment: 1000 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Hypertension

## Interventions

- **DRUG:** atherolive

## Key facts

- **NCT ID:** NCT05297110
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05297110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05297110, "Olive Leaf Extracts in the Control of Cardiovascular Risk". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05297110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*